Case Based Overview: Poor-Risk Advanced Renal Cell Carcinoma Targeted Oncology 2:53 4 years ago 161 Далее Скачать
Surgery for Poor-Risk Advanced Renal Cell Carcinoma Targeted Oncology 2:44 4 years ago 91 Далее Скачать
Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC PeerView Oncology 38:09 4 years ago 188 Далее Скачать
COSMIC-313: cabo + nivo + ipi in 1L advanced RCC of IMDC intermediate or poor risk VJOncology 4:01 1 year ago 273 Далее Скачать
Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023 Touch Medical Media 51:09 1 year ago 3 349 Далее Скачать
First-Line Treatment of Poor-Risk Metastatic Renal Cell Carcinoma OncLive 3:36 10 years ago 299 Далее Скачать
The Role of Tyrosine Kinase Inhibitors and mTOR Inhibitors Kidney Cancer 41:21 9 years ago 4 341 Далее Скачать
Selecting Novel Therapy for Advanced Renal Cell Carcinoma Targeted Oncology 5:23 4 years ago 51 Далее Скачать
In RCC, What Is the Optimal Treatment for Intermediate/Poor-Risk Disease? GU Oncology Now 6:17 1 year ago 296 Далее Скачать
Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma Targeted Oncology 1:37 4 years ago 1 732 Далее Скачать
Risk Stratification in Advanced Renal Cell Cancer Targeted Oncology 1:58 6 years ago 86 Далее Скачать
